RecruitingNot Applicable

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

South Korea2,000 participantsStarted 2023-12-14

Plain-language summary

The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients ≥ 19 years old
✓. Patients receiving Xience-Skypoint™ stents.
✓. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion criteria

✕. Patients with a mixture of other DESs
✕. Terminal illness with life expectancy \<1 year
✕. Patients with cardiogenic shock

What they're measuring

the composite event rate of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR)

Timeframe: 12 months

Trial details

NCT IDNCT05981911

SponsorSeung-Jung Park

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Jung-hee Ham, Project manager

82230104728 cvcrc5@amc.seoul.kr

View on ClinicalTrials.gov More Coronary Artery Disease trials